Biomerics Promotes Arun Mohan to CEO

Biomerics, a contract manufacturer for the interventional device market, has appointed Arun Mohan as its new CEO. Founder and current CEO Travis Sessions will move to the role of chairman of the board.

As CEO, Mohan will serve on the company’s board of directors and be responsible for its global business operations, financial performance, and strategic growth initiatives. He was previously president of Biomerics’ Micro Metals division, where he built a high-performing team. His leadership philosophy centers on customer centricity, employee empowerment, and innovation-driven execution.

“I am humbled and honored to lead Biomerics into its next chapter,” said Mohan. “Our mission is clear: to improve and save lives. To achieve this, we will place our customers at the center, invest in our people and advance manufacturing excellence as the foundation of everything we do. Together, we will innovate boldly, grow responsibly, and build a company that not only leads in medtech manufacturing, but also inspires pride in every employee and confidence in every customer.”

Sessions founded Biomerics in 1994 and said he will remain engaged as chairman—advising Mohan on strategic initiatives, including future mergers and acquisitions. Under his leadership, Biomerics grew from a single-site startup to a partner with over 3,000 employees at 12 locations in the U.S., the Dominican Republic and Costa Rica.

“This is a defining moment in Biomerics’ 30-year journey,” said Sessions. “Our success has always been rooted in innovation, manufacturing excellence and a relentless focus on serving our customers. Arun has the leadership, vision and proven track record to take Biomerics to the next level. With the full support of the board, I am confident that under his leadership, we will continue to deliver transformative solutions for patients while expanding our global footprint. I look forward to working alongside him as chairman.”